PRPO icon

Precipio

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
Seeking Alpha
2 months ago
Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript
Precipio, Inc. (NASDAQ:PRPO ) Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ET Company Participants Ilan Danieli - Founder, President, CEO & Director Operator Welcome to the Precipio Q2 2025 Shareholder Update Conference Call. [Operator Instructions] Please note that this conference is being recorded.
Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
2 months ago
Precipio Announces its Q2-2025 Financial Results
NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , filed its 10-Q report today.
Precipio Announces its Q2-2025 Financial Results
Neutral
GlobeNewsWire
2 months ago
Precipio Announces Q2-2025 Shareholder Update Call
NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00 PM ET.
Precipio Announces Q2-2025 Shareholder Update Call
Neutral
GlobeNewsWire
3 months ago
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a revised structure whereby 100,000 warrants (approximately ⅓) shall be exercised with cash, and the remainder (approximately 200,000 warrants) to be exercised in a cashless manner.
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
Neutral
Seeking Alpha
5 months ago
Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript
Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript
Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
5 months ago
Precipio Announces its Q1-2025 Financial Results
NEW HAVEN, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , filed its 10-Q report today.
Precipio Announces its Q1-2025 Financial Results
Neutral
GlobeNewsWire
5 months ago
Precipio Announces Q1-2025 Shareholder Update Call
NEW HAVEN, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q1-2025 corporate update call on May 15th, 2025 at 5:00 PM ET.
Precipio Announces Q1-2025 Shareholder Update Call
Neutral
Seeking Alpha
6 months ago
Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript
Precipio, Inc. (NASDAQ:PRPO ) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Conference Call Participants Operator Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update Conference Call. All participants will be in listen-only mode.
Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
7 months ago
Precipio Announces Q4 and year-end 2024 Shareholder Update Call
NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st, 2025 at 5:00 PM ET.
Precipio Announces Q4 and year-end 2024 Shareholder Update Call
Neutral
GlobeNewsWire
7 months ago
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)
Both metrics demonstrate the ability to achieve financial independence Both metrics demonstrate the ability to achieve financial independence
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)